S'abonner

Masking for COVID-19 Is Associated with Decreased Emergency Department Utilization for Non-COVID Viral Illnesses and Respiratory Conditions in Maryland - 28/09/21

Doi : 10.1016/j.amjmed.2021.06.008 
Zachary D.W. Dezman, MD, MS, MS a, b, , Benoit Stryckman, MA a, Kori S. Zachrison, MD, MSc c, Ryan M. Conrad, PhD d, David Marcozzi, MD, MHS-CL a, Laura Pimentel, MD a, Margaret Samuels-Kalow, MD, MPhil, MSHP c, Charles B. Cairns, MD e
a Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, Md 
b Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Md 
c Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 
d US Food and Drug Administration, Rockville, Md 
e Drexel University, Philadelphia, Penn 

Requests for reprints should be addressed to Zachary Dezman, MD, MS, MS, Department of Emergency Medicine, University of Maryland School of Medicine, 110 S Paca Street, 6th Floor, Suite 200, Baltimore, MD, 21201.Department of Emergency MedicineUniversity of Maryland School of Medicine110 S Paca Street, 6th Floor, Suite 200BaltimoreMD21201

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Masking, which is known to decrease the transmission of respiratory viruses, was not widely practiced in the United States until the coronavirus disease 2019 (COVID-19) pandemic. This provides a natural experiment to determine whether the percentage of community masking was associated with decreases in emergency department (ED) visits due to non-COVID viral illnesses (NCVIs) and related respiratory conditions.

Methods

In this observational study of ED encounters in a 11-hospital system in Maryland during 2019-2020, year-on-year ratios for all complaints were calculated to account for “lockdowns” and the global drop in ED visits due to the pandemic. Encounters for specific complaints were identified using the International Classification of Diseases, version 10. Encounters with a positive COVID test were excluded. Linear regression was used to determine the association of publicly available masking data with ED visits for NCVI and exacerbations of asthma and chronic obstructive pulmonary disease (COPD), after adjusting for patient age, sex, and medical history.

Results

There were 285,967 and 252,598 ED visits across the hospital system in 2019 and 2020, respectively. There was a trend toward an association between the year-on-year ratio for all ED visits and the Maryland stay-at-home order (parameter estimate = -0.0804, P = .10). A 10% percent increase in the prevalence of community masking was associated with a 17.0%, 8.8%, and 9.4% decrease in ED visits for NCVI and exacerbations of asthma exacerbations and chronic obstructive pulmonary disease, respectively (P < .001 for all).

Conclusions

Increasing the prevalence of masking is associated with a decrease in ED visits for viral illnesses and exacerbations of asthma and COPD. These findings may be valuable for future public health responses, particularly in future pandemics with respiratory transmission or in severe influenza seasons.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID, Emergency medicine, Epidemiology, Public health


Plan


 Funding: ZDWD, KSZ, the data extraction, and data analysis, were all supported through grants from National Foundation of Emergency Medicine. The National Foundation of Emergency Medicine was not involved in the development of the analysis or the contents of the report.
 Conflicts of Interest: ZDWD reports serving on an advisory board for Perdue Pharmaceuticals to assist with the development medications to be used against the opioid epidemic. CBC reports serving as a consultant to bioMerieux on biomarkers; as the President of the Board of Directors of the National Foundation of Emergency Medicine (NFEM), a non-profit organization dedicated to the development of emergency medicine research, innovation and investigators; and receives funding for COVID-19 research from the National Institutes of Health (NIAID, NHLBI) and the Bill & Melinda Gates Foundation. BS, RMC, DM, LP, MS-K report none.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 134 - N° 10

P. 1247-1251 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • Acute Hypoxia in a 78-Year-Old Female with Bacteremia and a History of Syphilis
  • Matthew J. Lacey, Keith B. Armitage, Ankur Kalra
| Article suivant Article suivant
  • Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections
  • Jennifer Y. So, Nathan N. O'Hara, Blaine Kenaa, John G. Williams, Christopher L. deBorja, Julia F. Slejko, Zafar Zafari, Michael Sokolow, Paul Zimand, Meagan Deming, Jason Marx, Andrew N. Pollak, Robert M. Reed

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.